ConductScience.org, home

Paper29902255

Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.

Schneider JS. PLoS One, 2018. Cited by 67 papers, by iCite.

Cite this record

ConductScience Library. Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease. Papers, record 29902255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29902255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson's disease.
PubMed
Journal
PLoS One
PubMed
Year
2018
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
67
iCite
Relative citation ratio, by iCite
3.13
iCite
Revised in PubMed
2023-09-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schneider JSJay Shttps://orcid.org/0000-0002-4565-146X

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GangliosidesMajor topic
Gene Expression RegulationMajor topic
NeuronsMajor topic
Parkinson DiseaseMajor topic
Substantia NigraMajor topic
Aged
Aged, 80 and over
Case-Control Studies
Female
Galactosyltransferases
Humans
Male
Melanins
Middle Aged
Sialyltransferases
beta-Galactoside alpha-2,3-Sialyltransferase

Source PubMed

Download CSV of topics

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13490632Administration of GM1 ganglioside restores the dopamine content in striatum after chronic treatment with MPTP.Neuropharmacology1986https://conductscience.org/library/papers/3490632PubMed
22565752GM1 ganglioside-induced recovery of nigrostriatal dopaminergic neurons after MPTP: an immunohistochemical study.Brain Res1989https://conductscience.org/library/papers/2565752PubMed
329747811Ganglioside Metabolism in Health and Disease.Prog Mol Biol Transl Sci2018https://conductscience.org/library/papers/29747811PubMed
417051204The roles of intracellular protein-degradation pathways in neurodegeneration.Nature2006https://conductscience.org/library/papers/17051204PubMed
512374199Ganglioside function in calcium homeostasis and signaling.Neurochem Res2002https://conductscience.org/library/papers/12374199PubMed
69706152Monosialoganglioside GM1 inhibits neurotoxicity after hypothermic circulatory arrest.Surgery1998https://conductscience.org/library/papers/9706152PubMed
78224473Structure and function of sphingoglycolipids in transmembrane signalling and cell-cell interactions.Biochem Soc Trans1993https://conductscience.org/library/papers/8224473PubMed
827836779Contribution of cholesterol and oxysterols to the pathophysiology of Parkinson's disease.Free Radic Biol Med2016https://conductscience.org/library/papers/27836779PubMed
99633704Parkinson's disease: improved function with GM1 ganglioside treatment in a randomized placebo-controlled study.Neurology1998https://conductscience.org/library/papers/9633704PubMed
1025762012GM1 Ganglioside: Past Studies and Future Potential.Mol Neurobiol2016https://conductscience.org/library/papers/25762012PubMed
118531220GM1 ganglioside rescues substantia nigra pars compacta neurons and increases dopamine synthesis in residual nigrostriatal dopaminergic neurons in MPTP-treated mice.J Neurosci Res1995https://conductscience.org/library/papers/8531220PubMed
121115656Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients.Arch Neurol1975https://conductscience.org/library/papers/1115656PubMed
1326024958The multi-tasked life of GM1 ganglioside, a true factotum of nature.Trends Biochem Sci2015https://conductscience.org/library/papers/26024958PubMed
144187718Sphingomyelin in Lewy inclusion bodies in Parkinson's disease.Arch Neurol1969https://conductscience.org/library/papers/4187718PubMed
1529518718Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling.J Chromatogr B Analyt Technol Biomed Life Sci2018https://conductscience.org/library/papers/29518718PubMed
1625075858N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation.PLoS One2014https://conductscience.org/library/papers/25075858PubMed
1719846850Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease.N Engl J Med2009https://conductscience.org/library/papers/19846850PubMed
1829459819Ganglioside Metabolism and Parkinson's Disease.Front Neurosci2018https://conductscience.org/library/papers/29459819PubMed
1924822250Altered ceramide acyl chain length and ceramide synthase gene expression in Parkinson’s disease.Mov Disord2014https://conductscience.org/library/papers/24822250PubMed
206438349Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.J Neurosci Res1984https://conductscience.org/library/papers/6438349PubMed

See all 41 referencesDownload CSV of references

Cited by52

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 67 citations.

PMIDTitleJournalYearIn PapersSource
42272075Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.Mov Disord2026https://conductscience.org/library/papers/42272075PubMed
41757160Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.medRxiv2026https://conductscience.org/library/papers/41757160PubMed
41581874Gangliosides in molecular interactions and cell regulation.J Biol Chem2026https://conductscience.org/library/papers/41581874PubMed
41489058Engineered GM1 Intersects Between Mitochondrial and Synaptic Pathways to Ameliorate ALS Pathology.Adv Sci (Weinh)2026https://conductscience.org/library/papers/41489058PubMed
41303601The Involvement of Ceramide, Sphingosine-1-Phosphate and Ganglioside GM1 in Regulating Some Nervous System Functions.Int J Mol Sci2025https://conductscience.org/library/papers/41303601PubMed
40745477When ganglioside pathways go awry: congenital disorders and experimental insights.J Hum Genet2025https://conductscience.org/library/papers/40745477PubMed
39630405EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson's Disease.Mol Neurobiol2025https://conductscience.org/library/papers/39630405PubMed
39404403An Optimized Liquid Chromatography-Mass Spectrometry Method for Ganglioside Analysis in Cell Lines.Cells2024https://conductscience.org/library/papers/39404403PubMed
38928016Sphingolipids: Less Enigmatic but Still Many Questions about the Role(s) of Ceramide in the Synthesis/Function of the Ganglioside Class of Glycosphingolipids.Int J Mol Sci2024https://conductscience.org/library/papers/38928016PubMed
38542297Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.Int J Mol Sci2024https://conductscience.org/library/papers/38542297PubMed
38235387Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology.Front Physiol2023https://conductscience.org/library/papers/38235387PubMed
38177695Exome sequencing identifies genes associated with sleep-related traits.Nat Hum Behav2024https://conductscience.org/library/papers/38177695PubMed
37368047Identification of atlastin genetic modifiers in a model of hereditary spastic paraplegia in Drosophila.Hum Genet2023https://conductscience.org/library/papers/37368047PubMed
37298512Ganglioside GM1 and the Central Nervous System.Int J Mol Sci2023https://conductscience.org/library/papers/37298512PubMed
37298133GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms.Int J Mol Sci2023https://conductscience.org/library/papers/37298133PubMed
37238977GM1 Oligosaccharide Efficacy in Parkinson's Disease: Protection against MPTP.Biomedicines2023https://conductscience.org/library/papers/37238977PubMed
36849668Restoration of Adult Neurogenesis by Intranasal Administration of Gangliosides GD3 and GM1 in The Olfactory Bulb of A53T Alpha-Synuclein-Expressing Parkinson's-Disease Model Mice.Mol Neurobiol2023https://conductscience.org/library/papers/36849668PubMed
36638010The relationship between depletion of brain GM1 ganglioside and Parkinson's disease.FEBS Open Bio2023https://conductscience.org/library/papers/36638010PubMed
36504680Altered expression of glycobiology-related genes in Parkinson's disease brain.Front Mol Neurosci2022https://conductscience.org/library/papers/36504680PubMed
36255682Gangliosides in Neurodegenerative Diseases.Adv Neurobiol2023https://conductscience.org/library/papers/36255682PubMed

See all 52 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29902255

GET https://conductscience.org/api/papers/v1/29902255/references?page=2